Krka Group

Krka has looked to brush aside any concerns that it will run into capacity constraint issues in the near term, as it continues to eye revenue growth of around 6% or more in 2025 to reach its group sal

Krka has maintained its strong performance in 2024 as seen in its latest nine-month results despite slightly missing net profit consensus forecasts amid ongoing questions surrounding the company’s bus

Krka believes that its financial results for the first six months of the year “are encouraging and that we will meet our plans for 2024,” after its prescription Pharmaceuticals sales rose by 9% to €8

The Court of Justice of the EU has rejected appeals and overturned certain elements of an earlier decision by Europe’s general court in the latest development in long-running litigation over perindopr